Market Access News | pharmaphorum

News

Insmed's chief medical officer Martina Flammer

FDA starts review of first bronchiectasis drug candidate

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.

News

Trump 'planning mass job cuts at US health agencies'

Media reports suggest the Trump administration is preparing a new executive order that would seek thousands of layoffs at federal health agencies.

News

Newel's VR therapy for chronic pain nears EU market

Newel Health has been granted EU certification for its VR-based digital therapeutic for chronic pain, clearing the way for its launch in Europe.

News

Graphic representation of an implant into an eyeball

FDA expands label for Roche's eye disease implant Susvimo

The renaissance of Roche's refillable ophthalmic implant Susvimo has continued with FDA approval for use in patients with diabetic macular oedema.

News

RFK Jr odds on for HHS role after Finance Committee vote

Robert F Kennedy Jr has cleared a key obstacle in his bid to become the next HHS Secretary after the Senate Finance Committee voted in his favour.

News

Hand pointing to viewer through map of China

Trump tariffs 'would strain the pharma supply chain'

Pharma organisations in the US have said that Trump's tariffs plan could drive up the cost of generics, block supply chains and worsen drug shortages.

FDA starts review of first bronchiectasis drug candidate

Trump 'planning mass job cuts at US health agencies'

Newel's VR therapy for chronic pain nears EU market

FDA expands label for Roche's eye disease implant Susvimo

RFK Jr odds on for HHS role after Finance Committee vote

Trump tariffs 'would strain the pharma supply chain'

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks